Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2026-01-06 @ 7:03 AM
Study NCT ID:
NCT04027361
Status:
COMPLETED
Last Update Posted:
2022-02-18
First Post:
2019-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)
Sponsor:
Tris Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-16
First Submit QC Date:
None
Study First Post Date:
2019-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-16
Last Update Post Date:
2022-02-18
Last Update Post Date Type:
ACTUAL